Synopsis
Synopsis
0
KDMF
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bisolvomycin
2. Geomycin
3. Hydroxytetracycline
4. Oxyterracin
5. Oxyterracine
6. Oxytetracid
7. Oxytetracycline
8. Oxytetracycline Anhydrous
9. Oxytetracycline Calcium
10. Oxytetracycline Dihydrate
11. Oxytetracycline Monohydrochloride
12. Oxytetracycline Sulfate (2:1)
13. Oxytetracycline, (4a Beta,5 Beta,5a Beta,12a Beta)-isomer
14. Oxytetracycline, (5 Beta)-isomer
15. Oxytetracycline, Anhydrous
16. Oxytetracycline, Calcium (1:1) Salt
17. Oxytetracycline, Disodium Salt, Dihydrate
18. Oxytetracycline, Sodium Salt
19. Terramycin
1. 2058-46-0
2. Oxytetracycline Hcl
3. Terramycin Hydrochloride
4. Oxytetracycline.hcl
5. Bisolvomycin
6. Terramycin
7. Dalimycin
8. Unimycin
9. Oxy-kesso-tetra
10. Alamycin
11. Imperacin
12. Mepatar
13. Oxacycline
14. Oxymykoin
15. Oxysteclin
16. Vendarcin
17. Oxytetracyclini Hydrochloridum
18. Dalinmycin
19. Engemycin
20. Oxamycen
21. Liquamycin Injectable
22. Aquacycline
23. Hydrocyclin
24. Oxybiocycline
25. Abbocin
26. Chrysocin
27. Elinton
28. Intaloxin
29. Liquachel
30. Macodyn
31. Otetryn
32. Oxlopar
33. Oxycycline
34. Oxyject
35. Oxytetral
36. Oxytetrin
37. Oxytracyl
38. Terraject
39. Toxinal
40. Biotet
41. Oxyvet
42. Oxy-dumocyclin
43. Tetra-tablinen
44. Oxy-terachel
45. Bi Steclin
46. Ia-loxin
47. Oxy-rivo
48. Uri-tet
49. Tetran Hydrochloride
50. 5-hydroxytetracycline Hydrochloride
51. Stecsolin
52. Oxydon
53. Tm 5
54. Oxy-tet 50
55. Tetracycline, 5-oxy-
56. Oxy-ws
57. Oxytetracycline (hydrochloride)
58. 4u7k4n52zm
59. Nsc 9169
60. Biosolvomycin
61. Chebi:31953
62. Oxy-de 250
63. 5-hydroxytetracycline Monohydrochloride
64. 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Monohydrochloride
65. Ncgc00091268-01
66. Oxytet
67. Terramycin (tn)
68. Dsstox_cid_1097
69. Component Of Terramycin Topical Ointment
70. Dsstox_rid_75939
71. Dsstox_gsid_21097
72. (4s,4ar,5s,5ar,6s,12ar)-4-(dimethylamino)-1,5,6,10,11,12a-hexahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
73. Oxy Ws
74. Oxyject 100
75. Caswell No. 628
76. Oxytetracycline Hydrochloride 100 Microg/ml In Acetonitrile
77. Oxatet
78. Hydroxytetrazyklinhydrochlorid
79. Ccris 200
80. Cas-2058-46-0
81. Tm 5 (van)
82. Nsc-757262
83. (4s,4ar,5s,5ar,6s,12as)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide Hydrochloride
84. Einecs 218-161-2
85. Epa Pesticide Chemical Code 006308
86. Unii-4u7k4n52zm
87. Neo-oxy 100/100 Mr
88. Ai3-50164
89. Oxytetracycline Hydrochloride (internal Use)
90. (4s,4ar,5s,5ar,6s,12as)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide;hydrochloride
91. Oxytetracycline Hydrochloride [jan]
92. Oxytetracycline Hydrochloride [usp:jan]
93. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, Monohydrochloride, (4s,4ar,5s,5ar,6s,12as)-
94. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, Monohydrochloride, (4s-(4alpha,4aalpha,5alpha,5aalpha,6beta,12aalpha))-
95. Schembl124996
96. Spectrum1500457
97. Chembl1607480
98. Chembl4549546
99. Chembl4591469
100. Dtxsid5021097
101. Hy-b0275a
102. Hms1920f04
103. Pharmakon1600-01500457
104. Tox21_111109
105. Tox21_201850
106. Tox21_300601
107. Ccg-40206
108. Mfcd00135815
109. Nsc757262
110. S5199
111. Oxytetracycline For System Suitability
112. Akos015950811
113. Nc00526
114. Ncgc00164443-01
115. Ncgc00254367-01
116. Ncgc00259399-01
117. (4s,5s,6s,12as,4ar,5ar)-4-(dimethylamino)-3,5,6,10,12,12a-hexahydroxy-6-methyl -1,11-dioxo-4,5,6,12a,4a,5a-hexahydronaphthacene-2-carboxamide, Chloride
118. Ac-11614
119. Oxytetracycline Hydrochloride (jp17/usp)
120. Oxytetracycline Hydrochloride [mi]
121. Cs-0013151
122. O0475
123. Oxytetracycline Hydrochloride [mart.]
124. Oxytetracycline Hydrochloride [vandf]
125. Oxytetracycline Hydrochloride [usp-rs]
126. Oxytetracycline Hydrochloride [who-dd]
127. Oxytetracycline Hydrochloride [who-ip]
128. D01596
129. Oxytetracycline Hydrochloride [green Book]
130. Oxytetracycline Hydrochloride [orange Book]
131. Oxytetracycline Hydrochloride [ep Monograph]
132. Oxytetracycline Hydrochloride [usp Monograph]
133. Oxytetracyclini Hydrochloridum [who-ip Latin]
134. Q27114732
135. Oxytetracycline Hydrochloride, >=95% (hplc), Crystalline
136. Terra-cortril Component Oxytetracycline Hydrochloride
137. Oxytetracycline Hydrochloride Component Of Terra-cortril
138. Oxytetracycline Hydrochloride, Vetranal(tm), Analytical Standard
139. Oxytetracycline Hydrochloride, European Pharmacopoeia (ep) Reference Standard
140. Oxytetracycline Hydrochloride, United States Pharmacopeia (usp) Reference Standard
141. 15000-39-2
142. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, Hydrochloride (1:1), (4s,4ar,5s,5ar,6s,12as)-
143. 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-, Monohydrochloride, (4s-(4.alpha.,4a.alpha.,5.alpha.,5a.alpha.,6.beta.,12a.alpha.))-
144. Oxytetracycline Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Molecular Weight | 496.9 g/mol |
---|---|
Molecular Formula | C22H25ClN2O9 |
Hydrogen Bond Donor Count | 8 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 2 |
Exact Mass | 496.1248581 g/mol |
Monoisotopic Mass | 496.1248581 g/mol |
Topological Polar Surface Area | 202 Ų |
Heavy Atom Count | 34 |
Formal Charge | 0 |
Complexity | 1000 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13390
Submission : 1998-09-01
Status : Active
Type : II
Century has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34794
Submission : 2020-07-22
Status : Active
Type : II
Date of Issue : 2022-11-02
Valid Till : 2024-12-16
Written Confirmation Number : WC-0293
Address of the Firm :
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13640
Submission : 1998-09-01
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13574
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13368
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13452
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13471
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13489
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13349
Submission : 1998-09-01
Status : Inactive
Type : II
About the Company : Suanfarma founded in 1993, is a B2B life science partner committed to health advancement by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical indus...
Century has been an API manufacturer for over 40 years & is the partner of choice for multipurpose custom manufacturing projects.
About the Company : Century Pharmaceuticals, established in 1982, has 40 years of experience in manufacturing APIs. It has been supplying APIs produced in-house to several major pharma companies in In...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
About the Company : Anhui Sinotech Industrial Co.,Ltd is specially engaged in international marketing of food/feed additive,pesticides and chemicals. We are devoted ourselves to make the life better,a...
About the Company : Arudavis Labs is in the business of manufacturing and trading of Active Pharmaceutical Ingredients and Formulations. We have been serving the Pharmaceutical and Biotechnology Indus...
About the Company : We can help your company solve the payment problems during the trading from chinese factories. We supply you with OEM from china.We are professsionals with the competitive price an...
About the Company : HANGZHOU THINK CHEMICAL CO., LTD. (THINKCHEM) is an integrative corporation of trade, research and contract manufacture. With about ten years of business experiences on the marketi...
About the Company : Hebei Veyong Pharmaceutical Co., Ltd, was established in 2002 and located in Economic and Technological Development Zone in Shijiazhuang. It is a large veterinary enterprise with G...
About the Company : QINGDAO QINGMEI BIOTECH(hereinafter referred to as Qingmei) is a specialized pharmaceutical company founded by DAYON INTERNATIONAL HOLDING LIMITED, which is to expand international...
About the Company : Founded in 1968 and based in the historic city of Leshan, Sichuan Long March Pharmaceutical Co., Ltd. is a major antibiotic API manufacturer in Southwest China. It operates under t...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
14
PharmaCompass offers a list of Oxytetracycline Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Oxytetracycline Hydrochloride manufacturer or Oxytetracycline Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oxytetracycline Hydrochloride manufacturer or Oxytetracycline Hydrochloride supplier.
PharmaCompass also assists you with knowing the Oxytetracycline Hydrochloride API Price utilized in the formulation of products. Oxytetracycline Hydrochloride API Price is not always fixed or binding as the Oxytetracycline Hydrochloride Price is obtained through a variety of data sources. The Oxytetracycline Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Oxytetral manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxytetral, including repackagers and relabelers. The FDA regulates Oxytetral manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxytetral API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxytetral manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxytetral supplier is an individual or a company that provides Oxytetral active pharmaceutical ingredient (API) or Oxytetral finished formulations upon request. The Oxytetral suppliers may include Oxytetral API manufacturers, exporters, distributors and traders.
click here to find a list of Oxytetral suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Oxytetral DMF (Drug Master File) is a document detailing the whole manufacturing process of Oxytetral active pharmaceutical ingredient (API) in detail. Different forms of Oxytetral DMFs exist exist since differing nations have different regulations, such as Oxytetral USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Oxytetral DMF submitted to regulatory agencies in the US is known as a USDMF. Oxytetral USDMF includes data on Oxytetral's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oxytetral USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Oxytetral suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Oxytetral Drug Master File in Japan (Oxytetral JDMF) empowers Oxytetral API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Oxytetral JDMF during the approval evaluation for pharmaceutical products. At the time of Oxytetral JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Oxytetral suppliers with JDMF on PharmaCompass.
A Oxytetral CEP of the European Pharmacopoeia monograph is often referred to as a Oxytetral Certificate of Suitability (COS). The purpose of a Oxytetral CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Oxytetral EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Oxytetral to their clients by showing that a Oxytetral CEP has been issued for it. The manufacturer submits a Oxytetral CEP (COS) as part of the market authorization procedure, and it takes on the role of a Oxytetral CEP holder for the record. Additionally, the data presented in the Oxytetral CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Oxytetral DMF.
A Oxytetral CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Oxytetral CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Oxytetral suppliers with CEP (COS) on PharmaCompass.
A Oxytetral written confirmation (Oxytetral WC) is an official document issued by a regulatory agency to a Oxytetral manufacturer, verifying that the manufacturing facility of a Oxytetral active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Oxytetral APIs or Oxytetral finished pharmaceutical products to another nation, regulatory agencies frequently require a Oxytetral WC (written confirmation) as part of the regulatory process.
click here to find a list of Oxytetral suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oxytetral as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Oxytetral API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Oxytetral as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Oxytetral and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oxytetral NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Oxytetral suppliers with NDC on PharmaCompass.
Oxytetral Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxytetral GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxytetral GMP manufacturer or Oxytetral GMP API supplier for your needs.
A Oxytetral CoA (Certificate of Analysis) is a formal document that attests to Oxytetral's compliance with Oxytetral specifications and serves as a tool for batch-level quality control.
Oxytetral CoA mostly includes findings from lab analyses of a specific batch. For each Oxytetral CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxytetral may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxytetral EP), Oxytetral JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxytetral USP).